---
title: "Stryker Corporation (SYK.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/SYK.US.md"
symbol: "SYK.US"
name: "Stryker Corporation"
industry: "Health Care Equipment"
datetime: "2026-04-29T02:40:40.523Z"
locales:
  - [en](https://longbridge.com/en/quote/SYK.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SYK.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SYK.US.md)
---

# Stryker Corporation (SYK.US)

## Company Overview

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Website | [www.stryker.com](https://www.stryker.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-04-28T04:30:16.000Z

**Overall: B (0.37)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 3 / 182 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Large - The company has stable operations, allowing for dependable long-term returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 11.16% |  |
| Net Profit YoY | 8.45% |  |
| P/B Ratio | 5.62 |  |
| Dividend Ratio | 1.05% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 126005649079.53 |  |
| Revenue | 25116000000.00 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 15.08% | A |
| Profit Margin | 12.92% | B |
| Gross Margin | 65.04% | A |
| Revenue YoY | 11.16% | B |
| Net Profit YoY | 8.45% | C |
| Total Assets YoY | 11.34% | B |
| Net Assets YoY | 8.66% | B |
| Cash Flow Margin | 155.39% | B |
| OCF YoY | 11.16% | B |
| Turnover | 0.55 | C |
| Gearing Ratio | 53.14% | C |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Stryker Corporation",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "11.16%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "8.45%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "5.62",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "1.05%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "126005649079.53",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "25116000000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "15.08%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "12.92%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "65.04%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "11.16%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "8.45%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "11.34%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "8.66%",
          "rating": "B"
        },
        {
          "name": "Cash Flow Margin",
          "value": "155.39%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "11.16%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.55",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "53.14%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 37.92 | 31/182 | 51.14 | 48.23 | 43.93 |
| PB | 5.49 | 109/182 | 7.01 | 6.61 | 6.20 |
| PS (TTM) | 4.90 | 93/182 | 6.29 | 5.88 | 5.54 |
| Dividend Yield | 1.07% | 16/182 | 0.95% | 0.90% | 0.85% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 03 | Stryker (SYK.US) | A | B | C | C | B | B |
| 04 | Boston Scientific (BSX.US) | A | B | E | A | C | B |
| 05 | IDEXX Labs (IDXX.US) | A | B | A | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-04-17T04:00:00.000Z

Total Analysts: **29**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 14 | 48% |
| Overweight | 8 | 28% |
| Hold | 7 | 24% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 321.43 |
| Highest Target | 469.00 |
| Lowest Target | 316.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/SYK.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/SYK.US/norm.md)
- [Related News](https://longbridge.com/en/quote/SYK.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/SYK.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**